Dr Harieta Garofide

Dr Harieta Garofide is a dedicated Consultant Medical Oncologist who provides comprehensive, patient-centred care to individuals facing cancer diagnoses. Holding key leadership roles as Clinical Director for Oncology and Lead for Systemic Anti-Cancer Therapies, she is deeply committed to maintaining high standards of clinical excellence, safety, and evidence-based practice. Her approach focuses on developing tailored treatment plans that address each individual's unique physical and emotional needs.

Specialising in the management of solid tumours, Dr Garofide has clinical focus in breast cancer and cancers of unknown primary. Her expertise spans a broad spectrum of systemic anti-cancer therapies, including conventional chemotherapy, endocrine therapy, targeted treatments, and advanced immunotherapies. Working closely with multidisciplinary care teams, she ensures seamlessly coordinated care, managing both complex oncological cases and the side effects of treatment to optimise overall quality of life for her patients.

In addition to her clinical commitments, Dr Garofide is actively involved in clinical research, clinical trials for novel cancer therapies, and healthcare quality improvement initiatives. She contributes to advancing cancer care standards through educational leadership, training junior medical staff, and promoting best practices in acute oncology management.